If only it were that simple. Just one dose of a newly developed Zika vaccine gives mice complete immunity to the disease. Safety trials in people are planned for October.
But some researchers warn there might be a major drawback – the vaccine might put people at greater risk from another more common virus, dengue. But the good news is that a more precisely targeted vaccine may eventually work for both diseases.
